Friday, July 17, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Healthcare

Just 40 Minutes a Week: New Research Lowers Bar for Dementia-Preventing Exercise

SiterGedge by SiterGedge
July 17, 2026
in Healthcare
0
FALLBACK Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

A fresh look at the latest World Health Organization guidelines, updated in 2026, suggests that up to 45 percent of dementia risk factors can be managed through lifestyle choices. While diet and social engagement remain important, the spotlight has shifted to targeted training — and the required time commitment is far smaller than many assume.

Researchers at the German Cancer Research Center (DKFZ) analysed existing data and published their findings in Frontiers in Public Health. The verdict: 40 to 60 minutes of strength training per week is enough to make a difference. The WHO recommends muscle-strengthening exercises twice a week, working all major muscle groups. Yet only 10 to 30 percent of adults currently meet that target, according to the study. To lower the entry barrier, DKFZ experts advocate accessible methods such as multi-joint exercises, supersets, or so-called “exercise snacks” — short, intense movement breaks scattered throughout the day.

Endurance training, meanwhile, has a clear effect on stress hormones. A randomised controlled trial conducted by the University of Pittsburgh and AdventHealth Research Institute tracked 130 adults aged 26 to 58 who exercised 150 minutes per week over twelve months. Cortisol levels in hair samples dropped significantly. Notably, blood pressure, inflammatory markers, and brain activity on MRI scans showed no comparable changes, indicating that the primary stress-reduction benefit of aerobic exercise is hormonal rather than systemic.

Beyond exercise, the WHO has broadened its prevention toolkit. New additions to its guidance include promoting social activities, using hearing aids for hearing loss, and improving air quality. Consistent treatment of accompanying conditions such as hypertension, diabetes, obesity, and depression remains a cornerstone. The organisation advises against vitamin supplements unless a deficiency has been confirmed.

Practical examples show how these principles translate into real-world settings. In mid-July, the 23rd AOK company run in Siegen drew a record 8,500 participants from more than 400 businesses, blending physical activity with team-building and social inclusion. In the care sector, the DRK day-care centre in Hermannsburg earned a certification in July after completing a year-long prevention programme developed with IKK classic and Esslingen University of Applied Sciences, focusing on maintaining independence through everyday movement. In Bad Waldsee, a prescription-based physiotherapy clinic opened in early June, and experts at information events have stressed that alongside training, adapting living spaces and preventing falls are essential pillars for an autonomous old age.

Tags: FALLBACK
SiterGedge

SiterGedge

Related Posts

Pentixapharm Stock
Analysis

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

July 17, 2026
FALLBACK Stock
Healthcare

Germany Orders Workers to Submit Medical Certificates from Day One After Absenteeism Costs Soar to €134 Billion

July 15, 2026
FALLBACK Stock
Banking & Insurance

Partial Incapacity to Work Introduced in Germany From 2027: New Three-Tier System for Sick Leave

July 15, 2026
Next Post
Meta Stock

From Cost Center to Cloud: Meta's Infrastructure Avalanche Meets a Skeptical Analyst

SANDISK Stock

SanDisk's Plunge Meets a Wall of Institutional Buying as Analysts Split on AI Demand

Micron Stock

Behind Micron’s 25% Rout: A Fully Booked HBM Pipeline and $25 Billion in New Factories

Recommended

Palantir Stock

Palantir’s Pentagon Partnership Faces AI Supply Chain Upheaval

4 months ago
First Majestic Silver Stock

First Majestic Silver’s Stock Volatility Mirrors Underlying Metal Prices

4 months ago
Rocket Lab USA Stock

Rocket Lab Shares Slide After Launch Scrub

7 months ago
Healthcare Services Stock Exchange

ProSomnus Supporting OSA Patients After Philips Respironics Discontinuation

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

Lang & Schwarz Trades Below Book Value as It Unveils €30m Structured Products Profit and €2 Dividend

Behind Micron’s 25% Rout: A Fully Booked HBM Pipeline and $25 Billion in New Factories

SanDisk’s Plunge Meets a Wall of Institutional Buying as Analysts Split on AI Demand

From Cost Center to Cloud: Meta’s Infrastructure Avalanche Meets a Skeptical Analyst

Just 40 Minutes a Week: New Research Lowers Bar for Dementia-Preventing Exercise

Trending

Allianz Stock
Analysis

Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply

by Kennethcix
July 17, 2026
0

For more than six months, Allianz shares have traded well above Jefferies' price target of €325 —...

Caterpillar Stock

Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

July 17, 2026
Applovin Stock

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

July 17, 2026
Pentixapharm Stock

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

July 17, 2026
Lang & Schwarz Stock

Lang & Schwarz Trades Below Book Value as It Unveils €30m Structured Products Profit and €2 Dividend

July 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply
  • Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds
  • AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com